Hadasit Bio-Holdings

Press Releases

Hadasit Bio Holdings Provides Convertible Loans to ProtAb Ltd. and Enlivex Ltd.

Jul. 30, 2012

Link to Hebrew immediate report

The company is pleased to announce that today, July 30, 2012, following approval of the Board of Directors on July 23, the Company provided two portfolio companies: ProtAb (69% ownership) and Enlivex (91% ownership) with convertible loans totaling about 2 million NIS (1 m NIS to each company). The terms of the loans are similar to the Company’s usual terms when providing loans to portfolio companies and includes conversion to preferred shares in a future investment round at a discount and with interest).

The loans are intended to support the two companies, allowing them to complete negotiations with external investors and complete preparation for a major clinical trial.

 
 

Press Releases Archive